COVID-19 Antigen

Abstract

The current reliable test recommended for the diagnosis of coronavirus disease 2019 (COVID-19) is the quantitative reverse transcription-polymerase chain reaction (RT-qPCR). Rapid antigen testing devices could be useful as they are less expensive and faster without the need for specialized laboratories to perform the test. We present the performance of two rapid immunochromatographic antigen test devices compared to RT-qPCR for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasopharyngeal specimens.

We conducted a lateral flow testing study on 401 nasopharyngeal swab samples from unduplicated COVID-19 suspect subjects. An equal volume of universal transport medium tubes containing samples (dilution ratio = 1:15) was added to the manufacturer’s extraction buffer (dilution ratio = 1: 2) and tested in the BioSpeedia COVID19Speed-Test. Antigen and Abbott Panbio ™ COVID-19 Ag Rapid Test, devices. The qualitative results were compared with those obtained by the RT-qPCR (Allplex ™ SARS-CoV-2 Assay Seegene).

Based on our data, the overall sensitivity for the BioSpeedia and Panbio devices was estimated to be 65.5% and 75.0%, respectively. Sensitivity was higher for cycle threshold values ​​below 25, achieving 90.4 and 96.8 for the BioSpeedia and Panbio devices, respectively. A perfect specificity of 100.0% was observed for both devices.

Keywords:

BioSpeedia; COVID-19; Panbio; RT-qPCR; SARS-CoV-2; antigen.

Conclusions from global trends

• Given the massive spread of COVID-19, worldwide PCR testing capacity is emphasized, therefore, many countries (including the USA, UK, Germany, France, Italy, Canada, and regional countries, etc.) are incorporating Ag-RDT into the disease mapping strategy.
• The WHO and CDC have recommended the use of Ag-RDT for high-risk groups, communities, high transmission areas, large surveys and screening.
• Ag-RDT is used in combination with the PCR test. Due to its false negativity aspects, RT PCR is mandatory for all negative symptomatic cases of Ag-RDT.

Justification of Ag-RDT in Pakistan

Based on the global experience of employing Ag-RDT in disease mapping, Pakistan (after an extensive consultative process) has decided to adopt rapid antigen testing to improve disease mapping and to complement PCR-based tests, but under strict control/monitoring. This will expand the number and scope of tests, especially in certain defined environments.

Leave a Comment